scholarly article | Q13442814 |
P50 | author | Fulvia Ceccarelli | Q86372522 |
Roberta Priori | Q87167983 | ||
Rolando Cimaz | Q88307472 | ||
Elena Elefante | Q89789613 | ||
Chiara Tani | Q89789616 | ||
Marta Mosca | Q90560735 | ||
Andrea Lojacono | Q91504092 | ||
Amelia Ruffatti | Q92104506 | ||
Marina Muscarà | Q96066549 | ||
Salvatore De Vita | Q114291040 | ||
Alessandro Mathieu | Q114314184 | ||
Melissa Padovan | Q114314189 | ||
Ariela Hoxha | Q114416255 | ||
Ma Tiziana Bertero | Q114417396 | ||
Silvia Breda | Q114417397 | ||
Marta Tonello | Q114417398 | ||
Laura Trespidi | Q114417399 | ||
Sonia Zatti | Q114417400 | ||
Emma Di Poi | Q114780706 | ||
Micaela Fredi | Q56468597 | ||
Antonio Brucato | Q57037188 | ||
Alessandra Bortoluzzi | Q58328427 | ||
Laura Andreoli | Q61806166 | ||
Véronique Ramoni | Q64015141 | ||
Franco Franceschini | Q69735842 | ||
Angela Tincani | Q73304219 | ||
Matteo Piga | Q37829183 | ||
Pier Luigi Meroni | Q38544871 | ||
Marcello Govoni | Q42410265 | ||
P2093 | author name string | Stefano Calza | |
Maria Gerosa | |||
Luca Marozio | |||
Veronica Cappa | |||
Antonina Minniti | |||
Beatrice Bacco | |||
P2860 | cites work | Congenital heart block not associated with anti-Ro/La antibodies: comparison with anti-Ro/La-positive cases | Q24653747 |
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation | Q26765038 | ||
Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues | Q31971105 | ||
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor | Q33335777 | ||
Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. | Q33343985 | ||
Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor. | Q33346093 | ||
Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus | Q33770770 | ||
Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach | Q34283166 | ||
Proposal for a new definition of congenital complete atrioventricular block. | Q35182018 | ||
Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. | Q35501152 | ||
Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. | Q35546634 | ||
Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease | Q35880901 | ||
Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus | Q36220831 | ||
Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies | Q36570988 | ||
The rate of recurrence of isolated congenital heart block: a population-based study | Q73565865 | ||
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women | Q74384559 | ||
Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study | Q80492903 | ||
Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group | Q80845149 | ||
Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model. | Q51557775 | ||
Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study. | Q51658934 | ||
Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies | Q57457905 | ||
Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets | Q57745725 | ||
Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone | Q60548226 | ||
Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block | Q61649461 | ||
Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies | Q70301080 | ||
Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block | Q72857261 | ||
Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. | Q37393128 | ||
Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside | Q37404476 | ||
Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system | Q37515813 | ||
The clinical spectrum of autoimmune congenital heart block | Q38387739 | ||
Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome | Q38568964 | ||
Fluorinated steroids do not improve outcome of isolated atrioventricular block | Q39302351 | ||
Should we treat congenital heart block with fluorinated corticosteroids? | Q40044899 | ||
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study | Q41936669 | ||
The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block. | Q43790634 | ||
Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients | Q46326249 | ||
Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution | Q46335688 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Italy | Q38 |
congenital heart block | Q18558252 | ||
Risk factors | Q57237748 | ||
P304 | page(s) | 11 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Frontiers in cardiovascular medicine | Q27726930 |
P1476 | title | First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) | |
P478 | volume | 6 |
Search more.